INNV-21. IN NEWLY-DIAGNOSED GLIOBLASTOMA, FRAILTY/SARCOPENIA PREDICTS 30D MORBIDITY & 30D, 90D, AND OVERALL MORTALITY AS ACCURATELY AS CURRENT STANDARDS

INTRODUCTION: Identification of novel prognostic biomarkers for glioblastoma (GBM) could stratify patients between aggressive or palliative treatments. Frailty, as measured by sarcopenia (lack of muscle mass), has been proven to predict survival in cancers. We evaluate whether the frailty/sarcopenia...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Zakaria, Hesham, Chandra, Ankush, Macki, Mohamed, Robin, Adam, Walbert, Tobias, Chang, Victor, Kalkanis, Steven, Lee, Ian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Innovations in Patient Care
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847745/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.564
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items